£27.20
4.82%
London, Oct 09, 04:36 pm BST. Closed.
ISIN
GB00B2B0DG97
Symbol
REL

RELX Stock price

£27.20
+2.05 8.15% 1M
+2.43 9.81% 6M
-3.00 9.93% YTD
-6.60 19.53% 1Y
-1.38 4.83% 3Y
+5.65 26.22% 5Y
+12.45 84.41% 10Y
+20.40 300.11% 20Y
London, Closing price Fri, Oct 09 2026
+1.25 4.82%
ISIN
GB00B2B0DG97
Symbol
REL

AI Insights on RELX Insights AI Insights on RELX

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is RELX a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,113 stocks worldwide.

Key metrics

Basic
Market capitalization
£45.1b
Enterprise Value
£53.8b
Net debt
£8.7b
Cash
£220.0m
Shares outstanding
1.7b
Valuation
P/E
21.9
P/S | estimate
4.6 | 4.3
EV/Sales | estimate
5.5 | 5.2
EV/FCF | ex SBC
23.2 | 23.8
P/B
36.4
Dividends
DPS
£0.68
Yield 1Y | 5Y
2.5% | 2.1%
Growth 1Y | 5Y
7.1% | 7.5%
Payout 1Y | 3Y
60.3% | 61.3%
Increased
15 Years
Financials
Revenue | estimate
£9.7b | £10.4b
EBITDA
£3.8b
EBIT
£3.1b
Net Income
£2.3b
Free Cash Flow | ex SBC
£2.3b | £2.3b
Growth
Revenue | estimate
2.0% | 8.1%
EBITDA
5.1%
EBIT
7.1%
Net Income
17.5%
Free Cash Flow
2.8%
Margin
Gross
66.4%
EBITDA
39.5%
EBIT
31.7%
Net
23.3%
Free Cash Flow | ex SBC
23.9% | 23.2%
Financial Health
Equity Ratio
16.0%
Return on Equity
87.3%
ROCE
36.1%
ROIC
22.0%
Debt/Equity
7.2
Share-Based Compensation & Dilution
SBC | % of Revenue
£64.0m | 0.7%
SBC as % of FCF
2.8%
SBC Growth 1Y
-3.0%
Share Count Growth 1Y
-4.5%
Shareholder Yield
7.0%
More
EPS
£1.2
FCF per Share
£1.3
Short interest
3,488.0%
Employees
37k
Rev per Employee
£260.0k

RELX Stock Analysis

Unlock Scores for Free

Analyst Opinions

25 Analysts have issued a RELX forecast:

22x Buy
88%
2x Hold
8%
1x Sell
4%

Analyst Opinions

25 Analysts have issued a RELX forecast:

Buy
88%
Hold
8%
Sell
4%

RELX Events

Upcoming Event
OCT
22
Q3 2026 Earnings Call
in 12 days
View Past Earnings Reaction
Past Events
JUL
23
Q2 2026 Earnings Call
3 months ago
MAY
13
Special Call - RELX PLC
5 months ago
FEB
12
Q4 2025 Earnings Call
8 months ago
OCT
23
Q3 2025 Earnings Call
12 months ago

Financial data from RELX

Jun '26
+/-
%
9,720 9,720
2% 2%
100%
- Direct Costs 3,264 3,264
1% 1%
34%
6,456 6,456
3% 3%
66%
- Selling and Administrative Expenses 3,377 3,377
0% 0%
35%
- Research and Development Expense - -
-
-
3,835 3,835
5% 5%
39%
- Depreciation and Amortization 756 756
2% 2%
8%
EBIT (Operating Income) EBIT 3,079 3,079
7% 7%
32%
Net Profit 2,262 2,262
18% 18%
23%

In millions GBP.

Don't miss a Thing! We will send you all news about RELX directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

RELX Stock News

Positive
Proactive Investors
●
11 days ago
RELX PLC (LSE:REL), the information and analytics group, has become increasingly disconnected from its improving earnings outlook as concerns over artificial intelligence and autonomous vehicles have pushed its shares down 17% this year. UBS reiterated its ‘buy' rating and 3,600p 12-month price target, arguing that investors have overstated the structural risks to the group's Legal and Risk div...
Neutral
PRNewsWire
●
18 days ago
Agencies now incur an average of $4.29 in total costs for every $1 lost to fraud as payment accuracy, data quality and eligibility challenges continue to mount. WASHINGTON, Sept.
Positive
Proactive Investors
●
3 months ago
RELX PLC (LSE:REL) is beginning to prove its doubters wrong by showing that artificial intelligence could accelerate growth rather than disrupt its business, although analysts believe further evidence is needed before the shares secure a substantial re-rating. Following first-half results from the FTSE 100 giant, Deutsche Bank retained its 'buy' recommendation and lifted its target to 3,100p fr...
More RELX News

Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity. The Risk & Business Analytics segment provides customers with solutions and decision tools that combine public and industry specific content with advanced technology and analytics to assist them in evaluating and predicting risk and enhancing operational efficiency. The Legal segment is a global provider of legal, regulatory and business information and analytics that helps customers increase productivity, improve decision-making and outcomes and advance the rule of law around the world. The Exhibitions segment is an event business, enhancing the effect of face-to-face through data and digital tools. The company was founded by Albert Edward Reed in 1894 and is headquartered in London, the United Kingdom.

Head office United Kingdom
CEO Mr. Engstrom
Employees 36,660
Founded 1903
Website www.relx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today